Regulations last checked for updates: May 18, 2024

Title 21 - Food and Drugs last revised: May 15, 2024
§ 26.35 - Length and purpose of transition period.

There will be a 3-year transition period immediately following the date described in § 26.80(a). During the transition period, the parties will engage in confidence-building activities for the purpose of obtaining sufficient evidence to make determinations concerning the equivalence of conformity assessment bodies (CAB's) of the other party with respect to the ability to perform quality system and product evaluations or other reviews resulting in reports to be exchanged under this subpart.

source: 63 FR 60141, Nov. 6, 1998, unless otherwise noted.
cite as: 21 CFR 26.35